Clinical Trials

A Phase Ib Multi-Cohort Trial of MK-3475 in Subjects with Hematologic Malignancies


Study ID
Merck MK-3475-013

NCT Number
NCT01953692 (Click on the NCT number for more information about the trial)

Research Study Number
00004296

Principle Investigator
Dr. David Siegel

Phase
I

Sponsor
Merck


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now